Acute Otitis Media Treatment Market Size 2021, by Growth Factors Consumption Volume, Top Regions and Countries, Trend Analysis, Development Status, and Forecast to 2025 | Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG and Novartis AG

Acute otitis media is a very painful kind of ear infection.

                       Acute Otitis Media Treatment




Acute otitis media is a very painful kind of ear infection. Acute otitis media occurs when the eardrum becomes infected and inflamed. Antibiotics are often the first line of therapy for acute otitis media.


Amoxicillin, cefaclor, cefprozil, cefurozime, cefixime, cefpodoxime, cefdinir, and azithromycin are often given antibiotics for the acute otitis media treatment. If antibiotics do not work, analgesics and antipyretics are used for the treatment of acute otitis media. Antihistamines and decongestants are prescribed by the physician for the treatment of acute otitis media in a few people.


Acute Otitis Media Treatment Market Segmentation:

By Formulation
  • Oral
  • Topical


By Drug Type
  • Antibiotics
  • Nonsteroidal anti-Inflammatory drug
  • Analgesic
  • Anaesthetic


By Distribution Channel
  • Hospital
  • Retail Pharmacies
  • Online Pharmacies



The rising prevalence of ear infections is a major driver of the worldwide acute otitis media treatment market.The development of innovative medications for the treatment of acute otitis media by prominent pharmaceutical firms will fuel the acute otitis media treatment market's rise. Acute otitis media therapy will also expand due to the availability of generic medications at a cheaper cost than branded pharmaceuticals for acute otitis media treatment.



Furthermore, prominent manufacturers in the development of medications for the treatment of acute otitis media are developing websites to broaden their consumer base and enhance their online business. The DROPS101 online tool, a mobile website that provides instructional information on common ear and eye treatments, was introduced by Alcon in 2013. DROPS101 Web Tools provides product information for acute otitis media therapy. The US FDA granted Aurobindo Pharma Ltd. permission to commercialise its generic medicine cefixime in the United States in 2015. Cefixime is a cephalosporin of the third generation that can be used to treat acute otitis media.


The major key players operating in the acute otitis media treatment market include Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG, Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company.

Comments

Popular posts from this blog

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.

Biolubricants Market Size, Share, Growth, Opportunities, Global Analysis and Opportunity Assessment 2019 – 2027

Shared Services Market by Function, By Number of Services and By Region – Global Opportunities & Forecast 2019 - 2027